Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1977-4-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0003-4738
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
116-8
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:190923-Administration, Oral,
pubmed-meshheading:190923-Asthma,
pubmed-meshheading:190923-Cyclic AMP,
pubmed-meshheading:190923-Humans,
pubmed-meshheading:190923-Leukocytes,
pubmed-meshheading:190923-Male,
pubmed-meshheading:190923-Metaproterenol,
pubmed-meshheading:190923-Middle Aged
|
pubmed:year |
1977
|
pubmed:articleTitle |
Paradoxical effects of oral metaproterenol on leukocyte adenosine 3',5'-monophosphate (cyclic AMP) levels in vivo.
|
pubmed:publicationType |
Journal Article,
Case Reports
|